Gene Therapy–Related Malignancy and the Risk of Cancer Exceptionalism Backfilling is generally considered a supplementary strategy in trials that still primarily aim to identify the MTD through ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results